The European Medicines Agency (EMA) and the United States Food …
FDA Grants Priority Review for Genzyme’s Cerdelga™ (eliglustat), an Investigational Oral Therapy for Gaucher Disease
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company announced today that the Food and Drug Administration …
We are pleased to announce that ALAN a.s.b.l. (Association Luxembourgeoise d’aide pour les personnes atteintes de maladies neuromusculaires et de maladies rares) has joined the EGA as a full member.
We are pleased to announce that Asociatia Pentru Boli Lizozomale Si Gaucher Din Republica Moldova, the Gaucher and Lysosomal Diseases Association of Moldova has joined the EGA as a full member.
There will be a whole host of presentations including:
We are pleased to announce that Hrvatski savez za rijetke bolesti, the Croatian Alliance for Rare Diseases, has joined the EGA as a full member.
We are pleased to announce that Asociación de Pacientes de Gaucher del Paraguay has joined the EGA as an associate member.
Gaucher patients, their families and doctors from Slovenia, Croatia, Bosnia & Herzegovina, Serbia, Montenegro and Macedonia met in Sarajevo, from 5th-7th April 2013.
The second regional meeting of Gaucher patients and The first regional meeting …
We are pleased to announce that The National Gaucher Foundation of Canada has joined the EGA as an associate member.